Tags

Type your tag names separated by a space and hit enter

A survey of folic acid use in primigravid women.
Women Birth. 2010 Jun; 23(2):67-73.WB

Abstract

A convenience sample of 320 consecutive primigravid women attending the antenatal clinic of a large Sydney tertiary referral hospital were invited to take part in a survey of folic acid use in pregnancy. The aim of the survey was to determine the number of primigravid women who commenced taking folic acid supplementation at least 1 month prior to conception. In addition the survey sought information on women's source of knowledge about the need for folic acid in pregnancy and whether their pregnancy was planned or unplanned. 295 women qualified to be included in the survey. While 88.1% of women took folic acid at some time prior to and/or during the first trimester, only 23.4% were found to have taken folic acid at least 1 month prior to conception. Of women with a planned birth only 34.5% commenced folic acid prior to conception. This survey adds further weight to the decision of the Australian Government to mandate for fortification of bread-making flour with folic acid, due to commence in September 2009. However, even with folic acid fortified food, health professionals need to continue to advise women to take supplements prior to conception and for at least 12 weeks into their pregnancy to prevent neural tube defects.

Authors+Show Affiliations

Practice Development Midwife-Delivery Suite, Al Wasl Hospital, Dubai, United Arab Emirates. DWilton@dha.gov.aeNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19828392

Citation

Wilton, Diane C., and Maralyn J. Foureur. "A Survey of Folic Acid Use in Primigravid Women." Women and Birth : Journal of the Australian College of Midwives, vol. 23, no. 2, 2010, pp. 67-73.
Wilton DC, Foureur MJ. A survey of folic acid use in primigravid women. Women Birth. 2010;23(2):67-73.
Wilton, D. C., & Foureur, M. J. (2010). A survey of folic acid use in primigravid women. Women and Birth : Journal of the Australian College of Midwives, 23(2), 67-73. https://doi.org/10.1016/j.wombi.2009.09.001
Wilton DC, Foureur MJ. A Survey of Folic Acid Use in Primigravid Women. Women Birth. 2010;23(2):67-73. PubMed PMID: 19828392.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A survey of folic acid use in primigravid women. AU - Wilton,Diane C, AU - Foureur,Maralyn J, Y1 - 2009/10/13/ PY - 2008/10/22/received PY - 2009/07/05/revised PY - 2009/09/13/accepted PY - 2009/10/16/entrez PY - 2009/10/16/pubmed PY - 2010/8/27/medline SP - 67 EP - 73 JF - Women and birth : journal of the Australian College of Midwives JO - Women Birth VL - 23 IS - 2 N2 - A convenience sample of 320 consecutive primigravid women attending the antenatal clinic of a large Sydney tertiary referral hospital were invited to take part in a survey of folic acid use in pregnancy. The aim of the survey was to determine the number of primigravid women who commenced taking folic acid supplementation at least 1 month prior to conception. In addition the survey sought information on women's source of knowledge about the need for folic acid in pregnancy and whether their pregnancy was planned or unplanned. 295 women qualified to be included in the survey. While 88.1% of women took folic acid at some time prior to and/or during the first trimester, only 23.4% were found to have taken folic acid at least 1 month prior to conception. Of women with a planned birth only 34.5% commenced folic acid prior to conception. This survey adds further weight to the decision of the Australian Government to mandate for fortification of bread-making flour with folic acid, due to commence in September 2009. However, even with folic acid fortified food, health professionals need to continue to advise women to take supplements prior to conception and for at least 12 weeks into their pregnancy to prevent neural tube defects. SN - 1878-1799 UR - https://www.unboundmedicine.com/medline/citation/19828392/A_survey_of_folic_acid_use_in_primigravid_women_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1871-5192(09)00069-9 DB - PRIME DP - Unbound Medicine ER -